COMMUNIQUÉS West-GlobeNewswire

Ellen AB inleder ett samarbete med Åhléns

23/09/2019 - 17:00

Åhléns som ingår i bolaget Axstores lanserar Ellens sortiment i sina butiker. Detta är en helt ny affär för Ellen och innebär att bolaget ytterligare kommer öka tillgängligheten av Ellens unika produktsortiment och [...]

Guardion Health Sciences Acquires the NutriGuard Brand of Products

23/09/2019 - 16:30

San Diego, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), through its newly-formed wholly-owned subsidiary, NutriGuard Formulations, Inc., has [...]

Coretrust Capital Partners and Connectivity Wireless Create Smart Building at FourFortyFour South Flower

23/09/2019 - 16:22

State-of-the-art technology from top to bottom brings 5G speeds to internet, uninterrupted cell service, conferencing assets, unlimited amenities LOS ANGELES, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Coretrust Capital [...]

Ozop Surgical Corp. Recognized as Most Innovative Surgical Implants & Instrumentation Manufacturer - USA by GHP

23/09/2019 - 15:30

GHP Announces the Healthcare & Pharmaceutical Awards 2019 Winners WEST PALM BEACH, FL, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium surgical devices [...]

Solos Introduces MammoView at ABSICON

23/09/2019 - 15:25

Solos Endoscopy, Inc. Successfully introduces MammoView at the Annual Conference of Association of Breast Surgeons of India WESTPORT, CT, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Solos Endoscopy, Inc. ( [...]

INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium

23/09/2019 - 15:03

LA JOLLA, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunotherapy company developing treatments which harness the patient’s innate immune system to fight disease, announced today [...]

Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019

23/09/2019 - 15:00

SOUTH SAN FRANCISCO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced [...]

FDA Grants Pediatric Disease Designation for Mateon’s OT101

23/09/2019 - 15:00

For treatment of diffuse intrinsic pontine glioma (DIPG), a difficult to treat form of childhood brain tumor AGOURA HILLS, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc. (OTCQB:MATN) announced today [...]

Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients

23/09/2019 - 15:00

Improved Functionality Across Four Valve Sizes and Lowest Delivery Profile on the Market, the Evolut PRO+ TAVR System Launches in U.S. as TAVR Patient Population Grows DUBLIN, Sept. 23, 2019 (GLOBE NEWSWIRE) -- [...]

Konica Minolta Healthcare CEO David Widmann to Share Insights on Creating Successful Strategic Partnerships at Health Connect South 2019 Annual Meeting

23/09/2019 - 15:00

WAYNE, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Health Connect South, the premier platform for regional health collaboration in the Southeast, will host David Widmann, President & CEO of Konica Minolta Healthcare [...]

Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S.

23/09/2019 - 15:00

Interactive memorial developed by the National Safety Council pays tribute to more than 22,000 victims of the opioid crisis and offers resources to help stem the epidemic Exhibit will be on display Sept. 23-28 at the [...]

Onconova Therapeutics, Inc. Announces $3.4 Million Registered Direct Offering of Common Stock

23/09/2019 - 14:52

NEWTOWN, Pa., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on [...]

Transactions under Novozymes’ stock buyback program

23/09/2019 - 14:48

Please read the full announcement in the attached PDF Attachment 2019_37_Stock_Buybackprogram_EN

Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa

23/09/2019 - 14:45

Company to provide additional transport stability data points in response to FDA Clinical Hold Letter CMC clearance for VIITAL™ trial anticipated in Q4 2019 Investor conference call today, Monday, September 23 at 09:30 [...]

Cannabix Technologies Expands Marijuana Breathalyzer Portfolio with Licensing of UBC Technology for Workplace and Parental Use

23/09/2019 - 14:45

Cannabix and UBC are working together to develop marijuana breathalyzer technology for a range of markets VANCOUVER, British Columbia, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: [...]

Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019

23/09/2019 - 14:30

Confirms BETonMACE database lock; reaffirms September 30, 2019 topline data availability CALGARY, Alberta, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announced today [...]

Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment

23/09/2019 - 14:30

VANCOUVER, British Columbia, and SEATTLE, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. ( TSX.V:PAS ) (“Pascal” or the “Company”) today revealed the mechanism whereby cannabinoids may directly aid in cancer [...]

Mustang Bio Announces Phase 1 Clinical Trial Evaluating MB-105 for Prostate Stem Cell Antigen-Positive Castration-Resistant Prostate Cancer Enrolling Patients at City of Hope

23/09/2019 - 14:30

NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

resTORbio to Present Findings on Investigational TORC1 Inhibitor RTB101 in Late-Breaking Session at IDWeek™ 2019

23/09/2019 - 14:09

BOSTON, Sept. 23, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc., (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related [...]